Aβ oligomers promote oligodendrocyte differentiation and maturation via integrin β1 and Fyn kinase signaling.
Tania Quintela-LópezCarolina Ortiz-SanzMari Paz Serrano-RegalAdhara Gaminde-BlascoJorge ValeroJimena BaleriolaMaria Victoria Sánchez-GómezCarlos MatuteElena AlberdiPublished in: Cell death & disease (2019)
Alzheimer´s disease (AD) is characterized by a progressive cognitive decline that correlates with the levels of amyloid β-peptide (Aβ) oligomers. Strong evidences connect changes of oligodendrocyte function with the onset of neurodegeneration in AD. However, the mechanisms controlling oligodendrocyte responses to Aβ are still elusive. Here, we tested the role of Aβ in oligodendrocyte differentiation, maturation, and survival in isolated oligodendrocytes and in organotypic cerebellar slices. We found that Aβ peptides specifically induced local translation of 18.5-kDa myelin basic protein (MBP) isoform in distal cell processes concomitant with an increase of process complexity of MBP-expressing oligodendrocytes. Aβ oligomers required integrin β1 receptor, Src-family kinase Fyn and Ca2+/CaMKII as effectors to modulate MBP protein expression. The pharmacological inhibition of Fyn kinase also attenuated oligodendrocyte differentiation and survival induced by Aβ oligomers. Similarly, using ex vivo organotypic cerebellar slices Aβ promoted MBP upregulation through Fyn kinase, and modulated oligodendrocyte population dynamics by inducing cell proliferation and differentiation. Importantly, application of Aβ to cerebellar organotypic slices enhanced remyelination and oligodendrocyte lineage recovery in lysolecithin (LPC)-induced demyelination. These data reveal an important role of Aβ in oligodendrocyte lineage function and maturation, which may be relevant to AD pathogenesis.
Keyphrases
- cognitive decline
- cell proliferation
- tyrosine kinase
- single cell
- protein kinase
- mild cognitive impairment
- high glucose
- multiple sclerosis
- stem cells
- gene expression
- endothelial cells
- minimally invasive
- genome wide
- poor prognosis
- electronic health record
- signaling pathway
- drug induced
- mesenchymal stem cells
- free survival
- amino acid
- small molecule
- heat shock protein
- white matter
- machine learning
- cell therapy
- protein protein
- cell migration